CEMI [NASD]
Chembio Diagnostics, Inc.
Index- P/E- EPS (ttm)-1.22 Insider Own0.10% Shs Outstand30.22M Perf Week-21.82%
Market Cap25.70M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float29.83M Perf Month8.23%
Income-36.10M PEG- EPS next Q-0.19 Inst Own9.20% Short Float4.93% Perf Quarter91.24%
Sales60.60M P/S0.42 EPS this Y-4.30% Inst Trans-4.18% Short Ratio1.78 Perf Half Y-10.37%
Book/sh0.66 P/B1.30 EPS next Y- ROA-52.20% Target Price- Perf Year-67.67%
Cash/sh0.76 P/C1.13 EPS next 5Y25.00% ROE-112.20% 52W Range0.42 - 3.38 Perf YTD-24.56%
Dividend- P/FCF- EPS past 5Y-2.10% ROI-58.10% 52W High-73.87% Beta1.65
Dividend %- Quick Ratio2.10 Sales past 5Y21.80% Gross Margin17.10% 52W Low112.69% ATR0.12
Employees337 Current Ratio2.90 Sales Q/Q41.50% Oper. Margin-54.50% RSI (14)54.67 Volatility10.82% 12.97%
OptionableYes Debt/Eq0.97 EPS Q/Q48.70% Profit Margin-59.50% Rel Volume0.73 Prev Close0.86
ShortableYes LT Debt/Eq0.81 EarningsAug 04 AMC Payout- Avg Volume824.01K Price0.88
Recom3.00 SMA208.05% SMA5017.47% SMA200-15.91% Volume165,314 Change2.69%
Jul-22-21Downgrade Colliers Securities Buy → Neutral
Dec-03-20Upgrade Craig Hallum Hold → Buy $5 → $10
Nov-06-20Upgrade Colliers Securities Neutral → Buy $7.50
Jun-17-20Downgrade The Benchmark Company Speculative Buy → Hold
Jun-17-20Downgrade Craig Hallum Buy → Hold
Jun-17-20Downgrade Canaccord Genuity Buy → Hold $7
May-26-20Initiated Robert W. Baird Outperform $21
Mar-04-20Reiterated The Benchmark Company Speculative Buy $9 → $6
Mar-04-20Reiterated The Benchmark Company Speculative Buy $9 → $5
Dec-19-18Initiated Dougherty & Company Buy
Aug-11-16Reiterated The Benchmark Company Speculative Buy $10 → $9
Apr-18-16Reiterated The Benchmark Company Speculative Buy $6 → $8
Nov-04-15Initiated The Benchmark Company Speculative Buy $6
Sep-10-13Resumed The Benchmark Company Speculative Buy $7
Aug-04-22 04:05PM  
Jul-21-22 04:05PM  
Jun-15-22 08:00AM  
May-24-22 04:15PM  
May-17-22 08:00AM  
May-05-22 04:05PM  
Apr-21-22 04:05PM  
Mar-03-22 04:05PM  
Feb-17-22 04:05PM  
Jan-10-22 05:38PM  
Jan-06-22 04:05PM  
07:29AM  
Jan-05-22 04:05PM  
Dec-29-21 06:46AM  
Dec-17-21 04:49PM  
Dec-06-21 08:00AM  
Nov-29-21 08:00AM  
Nov-22-21 08:00AM  
Nov-17-21 08:19AM  
Nov-16-21 04:05PM  
Nov-15-21 08:00AM  
Nov-09-21 05:12AM  
Nov-04-21 04:05PM  
Oct-21-21 04:51PM  
Sep-22-21 08:00AM  
Sep-10-21 07:02AM  
Aug-30-21 09:38AM  
Aug-27-21 03:43PM  
08:00AM  
06:30AM  
Aug-08-21 03:15AM  
Aug-06-21 10:46AM  
Aug-05-21 04:05PM  
Jul-22-21 05:03PM  
12:49PM  
01:04AM  
Jul-21-21 01:28PM  
08:50AM  
04:49AM  
04:35AM  
May-06-21 04:05PM  
02:30PM  
Apr-22-21 08:00AM  
Apr-07-21 02:51AM  
Apr-05-21 01:35PM  
11:43AM  
Apr-01-21 05:30PM  
Mar-11-21 04:05PM  
02:30PM  
Mar-10-21 10:13AM  
Mar-08-21 08:00AM  
Feb-25-21 04:05PM  
Feb-03-21 12:23AM  
Jan-14-21 07:00AM  
Dec-17-20 04:05PM  
Dec-05-20 02:15AM  
Dec-04-20 08:49AM  
Dec-03-20 08:48AM  
Dec-02-20 01:22PM  
Nov-27-20 01:10PM  
Nov-13-20 04:40PM  
Nov-05-20 04:05PM  
02:30PM  
Oct-23-20 08:00AM  
Oct-16-20 07:15AM  
Oct-15-20 05:55PM  
Oct-06-20 08:38AM  
Oct-02-20 10:10AM  
07:26AM  
Sep-25-20 08:55AM  
Sep-08-20 06:00PM  
Aug-25-20 08:57AM  
Aug-17-20 02:15PM  
11:50AM  
11:40AM  
11:01AM  
07:30AM  
06:55AM  
Aug-16-20 03:09PM  
11:44AM  
10:51AM  
Aug-15-20 02:35PM  
Aug-14-20 03:55PM  
02:25PM  
01:00PM  
12:00PM  
10:00AM  
09:31AM  
08:30AM  
Aug-13-20 07:40PM  
06:10PM  
02:25PM  
01:45PM  
12:45PM  
11:31AM  
10:30AM  
09:47AM  
Aug-12-20 04:45PM  
04:11PM  
04:10PM  
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, lassa, marburg, leptospirosis, rickettsia, and Burkholderia diseases. The company sells its products under the STAT-PAK, SURE CHECK, STAT VIEW, and DPP trademarks, as well as sells its products directly through distributors to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally. It has collaboration agreements with Bill & Melinda Gates Foundation, The Paul G. Allen Family Foundation, The Oswaldo Cruz Foundation, and the Foundation for Innovative New Diagnostics, as well as U.S. government agencies, such as Centers for Disease Control and Prevention, the Biomedical Advanced Research and Development Authority of the U.S. Department of Health and Human Services, and the U.S. Department of Agriculture. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Hauppauge, New York.